AP_Cardio_Contents.qxp 27/2/09 02:29 Page 3
Contents
Advisory Panel
6
Forewords
Koichiro Niwa 7
Director, Department of Adult Congenital Heart Disease and Paediatrics, Chiba Cardiovascular Centre, Japan
Masatsugu Hori 8
President Elect, International Society for Heart Research (ISHR)
Atrial Fibrillation
Current Advances in Catheter Ablation for Atrial Fibrillation –
Its Current Role and Outcomes with Different Strategies 9
Teiichi Yamane
1
and Masayasu Hiraoka
2
1. Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine;
2. Department of Cardiovascular Diseases, Medical Research Institute, Tokyo Medical and Dental University
Cholesterol Management and Risk Reduction
Cardiovascular Disease Risk Management in Diabetes –
The Implications of the REALITY Asia Study 12
Peter Yan
Cardiologist, Gleneagles Hospital and Mount Elizabeth Hospital, Singapore
Cholesterol Management and Risk Reduction –
Current Guidelines and Barriers to Goal Attainment 16
Geoff Holt
1
and Patrick Wong
2
1. Cardiologist and Medical Director, Heart Care Group; 2. Senior Medical Writer, Touch Briefings
ENHANCE – After the Dust Has Settled, Is Low-density Lipoprotein
Cholesterol Lowering What It Once Was? 21
Evan A Stein
Director, Metabolic and Atherosclerosis Research Center, Cincinnati
The Australian Diabetes, Obesity and Lifestyle Study –
Profiling Diabetes and Cardiovascular Disease Risk in the Nation 25
Adrian J Cameron, Paul Z Zimmet, Robert C Atkins and Jonathan E Shaw
International Diabetes Institute, Melbourne
Cardiovascular Risk Assessment and Primary Prevention in the
Era of Plaque Imaging 29
Cesare Rusconi
President, European Society for Non-invasive Cardiovascular Dynamics
Hypertension
The Impact of Getting Patients with Both Hypertension and
High Cholesterol to Target 33
MJ Penny and KA Duggan
Hypertension Laboratory, Liverpool Hospital, Sydney
Importance of Aortic Dimensions in Determining
Pulse Pressure in Elderly Hypertensives 35
David A Bertovic
1
and Anthony M Dart
2
1. Cardiologist and Research Fellow; 2. Medical Director, Cardiovascular Directorate, Alfred Hospital, Melbourne
Aliskiren for Direct Renin Inhibition in Hypertension 38
Hae-Young Lee and Byung-Hee Oh
Department of Internal Medicine, Seoul National University College of Medicine
ASIA-PACIFIC CARDIOLOGY 3
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84